Table of contents

Therapeutics

• Escitalopram 10 mg daily is more effective than paroxetine and placebo for generalised anxiety disorder (25 April, 2007)
• Review: little evidence to support dose escalation of selective serotonin reuptake inhibitors in non-responders (25 April, 2007) Free
• Decision support for primary care clinicians improves process of care but not symptoms in people with depression (25 April, 2007)
• Review: enhanced primary care programmes are effective for people with depression but are associated with increased healthcare costs (25 April, 2007)
• Benefits of bright light in non-seasonal major depression not sustained after discontinuation (25 April, 2007)
• Review: pharmacotherapy and psychotherapy similarly effective for depression in older adults (25 April, 2007)
• IMPACT collaborative care programme reduces suicide ideation in depressed older adults (25 April, 2007)
• Review: selective and indicated programmes are more effective than universal programmes for preventing depression in children and adolescents at 6 month follow-up (25 April, 2007)
• Review: evidence-based treatments are more effective than usual care for youths with psychological problems and maladaptive behaviour (25 April, 2007)
• Review: effects of behavioural parent training and cognitive-behavioural therapy on antisocial behaviour in children remain unclear (25 April, 2007)
• Brief cognitive-behavioural therapy reduces hospital readmission but does not reduce overall symptoms of schizophrenia (25 April, 2007)
• Quetiapine is no less effective than risperidone for reducing symptoms of schizophrenia (25 April, 2007)
• Clozapine improves symptoms but not quality of life compared with other second-generation antipsychotics in people with treatment resistant schizophrenia (25 April, 2007)
• Time to discontinuation similar for atypical antipsychotic drugs and placebo in people with Alzheimer’s disease (25 April, 2007)
• Oxcarbazepine is no more effective than placebo for reducing manic symptoms of bipolar I disorder in children and adolescents (25 April, 2007)
• Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD (25 April, 2007)